Novartis India (BOM:500672) Other Net Income (Loss) : ₹-0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1991. Start your Free Trial

What is Novartis India Other Net Income (Loss)?

Novartis India's Other Net Income (Loss) for the three months ended in Mar. 2024 was ₹0 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 was ₹-0 Mil.

Novartis India's quarterly Other Net Income (Loss) declined from Sep. 2023 (₹0 Mil) to Dec. 2023 (₹-0 Mil) but then increased from Dec. 2023 (₹-0 Mil) to Mar. 2024 (₹0 Mil).

Novartis India's annual Other Net Income (Loss) stayed the same from Mar. 2022 (₹0 Mil) to Mar. 2023 (₹0 Mil) but then declined from Mar. 2023 (₹0 Mil) to Mar. 2024 (₹-0 Mil).

Novartis India Other Net Income (Loss) Historical Data

The historical data trend for Novartis India's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Other Net Income (Loss) Chart

Novartis India Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Net Income (Loss)

Get a 7-Day Free Trial

Novartis India Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Net Income (Loss)	Get a 7-Day Free Trial															-	-	-	-	-

Novartis India Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹-0 Mil.

Novartis India Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Novartis India's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Novartis India (BOM:500672) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Other Net Income (Loss)

Traded in Other Exchanges

N/A

Address

Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051

Website

https://www.novartis.in

Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines